Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03037983 · ClinicalTrials.gov registry record · NA

Improving Neurocognitive Deficits and Function in Schizophrenia With Transcranial Magnetic Stimulation

A NA study of Schizophrenia and Schizoaffective Disorder, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
9
Enrollment target
1
Study location

NCT03037983: Completed NA study of Schizophrenia and Schizoaffective Disorder, sponsored by VA Office of Research and Development.

NCT03037983 is a NA study of Schizophrenia and Schizoaffective Disorder that has completed, run by VA Office of Research and Development. The registered enrollment target is 9 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03037983, a NA study of Schizophrenia and Schizoaffective Disorder, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
9 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether repetitive transcranial magnetic stimulation (rTMS) is effective in remediating cognitive deficits while also improving functionality in Veterans with schizophrenia.

Primary Outcome

Changes in scores for working memory performance accuracy will serve as dependent measure for testing the hypothesis that rTMS improves working memory. Working memory performance was assessed using a non-standardized task developed in house, which is basically a Sterberg style delayed response task in which memoranda are displayed and are to be remembered across a short delay period. The hypothesis will be supported if the investigators find greater working memory difference in the active compar

Conditions Studied

Schizophrenia Schizoaffective Disorder

Interventions

  • DEVICE Sham
  • DEVICE Repetitive transcranial magnetic stimulation

Study Locations (1)

California

  • VA Palo Alto Health Care System, Palo Alto, CA - Palo Alto

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2017-08-01
Est. Completion 2019-07-18
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT03037983 record still lists

NCT03037983 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (96% lower).

The record links to 2 conditions, with Schizophrenia appearing as the primary indexed condition, and to 2 interventions - of which Sham is the first listed.

NCT03037983 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT03037983 about?

NCT03037983 is a clinical study titled "Improving Neurocognitive Deficits and Function in Schizophrenia With Transcranial Magnetic Stimulation". The purpose of this study is to determine whether repetitive transcranial magnetic stimulation (rTMS) is effective in remediating cognitive deficits while also improving functionality in Veterans with schizophrenia.

What is the current status of trial NCT03037983?

This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2017-08-01. Estimated completion is 2019-07-18.

What conditions does trial NCT03037983 study?

This clinical trial studies the following conditions: Schizophrenia, Schizoaffective Disorder.

What interventions are being tested in trial NCT03037983?

The interventions under investigation include: Sham (DEVICE), Repetitive transcranial magnetic stimulation (DEVICE).

Who is sponsoring clinical trial NCT03037983?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03037983 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03037983's enrollment target sits among peer trials

9 313th of 315 higher than 3 of 315 other Schizophrenia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Schizophrenia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT03037983, the US trial registry maintained by the National Library of Medicine. NCT03037983 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.